CCEL लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 01:29):

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use...

Stats
आज की मात्रा	8 373.00
औसत मात्रा	11 308.00
बाजार मूल्य	69.46M
EPS	$0 ( 2024-04-19 )
अगली कमाई की तारीख	( $0.0400 ) 2024-07-12
Last Dividend	$0.900 ( 2022-09-01 )
Next Dividend	$0 ( N/A )
P/E	-7.39
ATR14	$0.0860 (1.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-22	Portnoy Mark L.	Buy	25 000	Stock Option
2023-12-22	Mikulinsky Oleg	Buy	10 000	Stock Option
2023-12-22	Taymans Jill M	Buy	10 000	Stock Option
2023-12-22	Portnoy David	Buy	50 000	Stock Option
2023-10-10	Berger Harold D.	Buy	5 300	Stock Option

INSIDER POWER
81.81
Last 100 transactions
Buy: 2 158 485 \| Sell: 773 682

Cryo-Cell International, सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Cryo-Cell International, वित्तीय

Annual	2023
राजस्व:	$31.34M
सकल लाभ:	$22.90M (73.07 %)
EPS:	$-1.140

FY	2023
राजस्व:	$31.34M
सकल लाभ:	$22.90M (73.07 %)
EPS:	$-1.140

FY	2022
राजस्व:	$30.34M
सकल लाभ:	$21.54M (71.02 %)
EPS:	$0.330

FY	2021
राजस्व:	$28.88M
सकल लाभ:	$19.90M (68.88 %)
EPS:	$0.260

Financial Reports:

No articles found.

Cryo-Cell International, Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.900 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cryo-Cell International, Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 2.12 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.900	2022-09-01
Last Dividend	$0.900	2022-09-01
Next Dividend	$0	N/A
Payout Date	2022-09-09
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.900	--
Avg. Dividend % Per Year	0.00%	--
Score	0.32	--
Div. Sustainability Score	0
Div.Growth Potential Score	2.12
Div. Directional Score	1.037	--

Next Divdend (Est)
(2024-05-03)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.32

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for PNK

Symbol	Title	Last dividend	Frequency	Yearly Dividend
ENBP	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
CMTV	Ex Dividend Knight	2023-10-12	Quarterly	0.00%
UEPEP	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
RSRV	Ex Dividend Junior	2023-06-06	Annually	0.00%
NUVR	Ex Dividend Junior	2023-06-02	Quarterly	0.00%
FMFG	Ex Dividend Knight	2023-06-01	Semi-Annually	0.00%
CZFS	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
BEBE	Ex Dividend Junior	2023-09-18	Quarterly	0.00%
TBTC	Ex Dividend Junior	2023-08-31	Sporadic	0.00%
QNBC	Ex Dividend Knight	2023-09-14	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.310	1.500	-6.20	-9.31	[0 - 0.5]
returnOnAssetsTTM	-0.158	1.200	-5.26	-6.31	[0 - 0.3]
returnOnEquityTTM	1.750	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.488	0.800	-2.56	-2.05	[1 - 3]
quickRatioTTM	0.398	0.800	-2.37	-1.892	[0.8 - 2.5]
cashRatioTTM	0.0128	1.500	-1.040	-1.560	[0.2 - 2]
debtRatioTTM	0.187	-1.500	6.88	-10.00	[0 - 0.6]
interestCoverageTTM	-12.82	1.000	-5.86	-5.86	[3 - 30]
operatingCashFlowPerShareTTM	0.838	2.00	9.72	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.0972	2.00	-0.0486	-0.0972	[0 - 20]
debtEquityRatioTTM	-1.118	-1.500	-4.47	6.71	[0 - 2.5]
grossProfitMarginTTM	0.728	1.000	1.201	1.201	[0.2 - 0.8]
operatingProfitMarginTTM	-0.420	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.599	1.000	7.78	7.78	[0.2 - 2]
assetTurnoverTTM	0.508	0.800	9.94	7.96	[0.5 - 2]
Total Score				-0.0519

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.27	1.000	-0.835	0	[1 - 100]
returnOnEquityTTM	1.750	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0972	2.00	-0.0324	-0.0972	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.838	2.00	9.72	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0163	1.500	-3.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.221	1.000	6.99	0	[0.1 - 0.5]
Total Score				2.12

Cryo-Cell International,

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.